# AppenDectomy Vs ANti TNF-a in Inducing Clinical and EnDoscopic Remission in Left-sided Ulcerative Colitis

> **NCT05931458** · NA · NOT_YET_RECRUITING · sponsor: **Federico II University** · enrollment: 94 (estimated)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **PROCEDURE:** Appendectomy
- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT05931458
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-07-01
- **Primary completion:** 2024-07-01
- **Final completion:** 2028-07-01
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2023-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05931458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05931458, "AppenDectomy Vs ANti TNF-a in Inducing Clinical and EnDoscopic Remission in Left-sided Ulcerative Colitis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05931458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
